Clinical Trials in Belgium

• Phase 3 study of pembrolizumab plus lenvatinib in endometrial carcinoma Ended
  2023-505614-17-00 Phase III Participants with advanced or recurrent endometrial carcinom… Merck Sharp & Dohme LLC
• A study to learn about the effects and safety of obeticholic acid in combination with bezafibrate in participants with primary biliary chola… Ended
  2024-513762-18-00 Phase II Primary Biliary Cholangitis (PBC) Intercept Pharmaceuticals Inc.
• Buspirone for weak or absent esophageal peristalsis Ended
  2024-516667-91-00 Phase IV ineffective motility or absent peristalsis UZ Leuven
• A Single-arm Study of Intrathecal SHP611 in Subjects with Metachromatic Leukodystrophy Ended
  2024-514402-31-00 Phase II Late Metachromatic Leukodystrophy (MLD) Shire Human Genetic Therapies Inc.
• A Long-term Safety Extension Study of Mavacamten (MYK-461) in Adults with Hypertrophic Cardiomyopathy Who Have Completed the MAVERICKHCM (MY… Ended
  2022-502858-14-00 Phase III Hypertrophic cardiomyopathy Myokardia Inc.
• Nivo versus Nivo/Ipi or versus other chemotherapies to treat colorectal cancer Ended
  2023-503956-29-00 Phase III Microsatellite Instability High (MSI-H) or Mismatch Repair D… Bristol-Myers Squibb Services Unlimited Company
• The Late Presenter Treatment Optimisation Study (LAPTOP) Ended
  2023-505167-36-00 Phase III Patients who present late on during their acquisition of the… NEAT ID Foundation
• A study comparing current standard therapies with fedratinib for the treatment of myelofibrosis (either diagnosed alone or after polycythemi… Ended
  2024-511972-33-00 Phase III Primary myelofibrosis, post-polycythemia vera myelofibrosis … Celgene Corp.
• Phase 3b/4 Study in Rheumatoid Arthritis Ended
  2023-508022-10-00 Phase IV Rheumatoid Arthritis Eli Lilly & Co.
• OPTIMIZE Ended
  2024-516509-22-00 Phase IV kidney transplant Universitair Medisch Centrum Groningen
• Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine Ended
  2023-504928-26-00 Phase III Chronic Migraine Amgen Inc.
• A study to assess different investigational drugs for the treatment if hidradenitis suppurativa Ended
  2023-509296-16-00 Phase II Moderate to severe hidradenitis suppurativa Novartis Pharma AG
• A Phase 3, Multicenter, Randomized, Open-label Study to Compare the Efficacy and Safety of bb2121 Versus Standard Regimens in Subjects with … Ended
  2023-509848-10-00 Phase III Multiple myeloma (MM) with at least 2 prior therapies includ… Celgene Corp.
• A global study to evaluate peri-operative pembrolizumab with chemotherapy versus placebo to pembrolizumab plus chemotherapy in cisplatin eli… Ended
  2022-501970-20-01 Phase III Cis-eligible Muscle-invasive bladder cancer. Merck Sharp & Dohme LLC
• A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specifi… Ended
  2024-511798-31-00 Phase I (FiH) KRAS p.G12C Mutant Advanced Solid Tumors Amgen Inc.
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Ended
  2023-503673-38-00 Phase III Adults at high risk of cardiovascular events without prior M… Amgen Inc.
• Adjuvant Therapy with Pembrolizumab Versus Placebo in Participants with Hepatocellular Carcinoma and Complete Radiological Response after Su… Ended
  2022-501971-24-00 Phase III Adjuvant treatment of HCC Merck Sharp & Dohme LLC
• A study evaluating the efficacy and safety of ralinepag in treatment of patients with pulmonary arterial hypertension. Ended
  2023-509304-16-00 Phase III Pulmonary arterial hypertension (PAH) United Therapeutics Corp.
• A Phase 1/2/3 Study to Evaluate the Safety and Efficacy of a Single Dose of Autologous CRISPR-Cas9 Modified CD34+ Human Hematopoietic Stem a… Ended
  2024-516067-83-00 Phase I (FiH) Severe sickle cell disease (SCD) Vertex Pharmaceuticals Inc.
• EASE SBS 2 (Evaluation of the efficacy and safety of Glepaglutide in the treatment of short bowel syndrome) (SBS) Ended
  2024-513374-22-00 Phase III Short Bowel Syndrome Zealand Pharma A/S
• Acute-On-Chronic Liver Failure (ACLF) at High Risk of Hospital Mortality Ended
  2022-502187-20-00 Phase III Subjects with cirrhosis with ACLF-1b, ACLF-2, or ACLF-3a det… Instituto Grifols S.A.
• HELIOS-A: A Phase 3 Global Study to Evaluate the Efficacy and Safety of ALN-TTRSC02 in Patients with Hereditary Transthyretin Amyloidosis Ended
  2023-508365-33-00 Phase III Hereditary Transthyretin Amyloidosis Alnylam Pharmaceuticals Inc.
• A safety and efficacy study of ABT-494 in subjects with Giant Cell Arteritis. Ended
  2023-505476-29-00 Phase III Giant Cell Arteritis AbbVie Deutschland GmbH & Co. KG
• Efficacy and safety of tisotumab vedotin (HuMax®-TF-ADC) monotherapy and in combination in recurrent or Stage IVB cervical cancer Ended
  2023-508832-68-00 Phase I/II Recurrent or stage IVB cervical cancer Genmab A/S

Showing 2,257–2,280 of 2,369 trials